Phototherapy

Clinics in Dermatology

Volumn 15, Issue 5, 1997, Pages 753-767

  Nee, Tham Siew ^a  

^a GLENEAGLES HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIPOTRIOL; CALCIUM; CELL ADHESION MOLECULE; COAL TAR; CORTICOSTEROID; CYTOKINE; DITHRANOL; DNA; EMOLLIENT AGENT; ETRETIN; ETRETINATE; FLUOCINOLONE; GLYCEROL; HAPTEN; HISTAMINE; INDOMETACIN; LANOLIN ALCOHOL; LIQUID PARAFFIN; METHOTREXATE; METHOXSALEN; MINERAL OIL; PROSTAGLANDIN E2; PROSTAGLANDIN INHIBITOR; PROTEIN; PYRIMIDINE; RNA; TAR; UNINDEXED DRUG; WHITE PETROLATUM;

CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; NONHUMAN; PHENOTYPE; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN; SKIN ATROPHY; SKIN DISCOLORATION; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET B RADIATION;

EID: 0343471434     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(97)00016-3     Document Type: Article

References (111)

1. Anderson TF, Waldinger TP, Voorhers JJ. UV-B phototherapy. Arch Dermatol 1984;120:1502-7.
2. Coopman SA, Stern RS. Phototherapy with ultraviolet B. In: Lim HW, Soter NA, editors. Clinical photomedicine. New York: Marcel Dekker, 1993:307-26.
3. Le Vine MJ, White HAD, Parrish JA. Components of the Goeckerman regimen. J Inv Dermatol 1979;73:170-3.
4. Le Vine MJ, Parrish JA. Outpatient phototherapy of psoriasis. Arch Dermatol 1980;! 16:552-4.
5. Lowe NJ, Wortzman MS, Breeding J, et al. Coal tar phototherapy for psoriasis re-evaluated: Erythemogenic vs suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. J Am Acad Dermatol 1983;8:781-9.
6. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981;76:359-62.
7. Fisher T. UV-light treatment of psoriasis. Acta Derm Venereol (Stockh) 1976;56:473-9.
8. Fisher T, Alsins J, Berne B. Ultraviolet action spectrum and evaluation of ultraviolet lamps for psoriasis healing. Int J Dermatol 1984;23:633-7.
9. Van Weelden H, van der Leun JC. Improving the effectiveness of phototherapy for psoriasis (Abstract). Br J Dermatol 1984;111:484.
10. Honigsmann H, Calzavara-Pinton PG, Ortel B. Phototherapy and photochemotherapy In: Dubertret L, editor. Psoriasis. Brescia, Italy: ISED, 1994:135-50.
11. Epstein JH, Fukuyama K, Epstein WL. UVL-induced stimulation of DNA synthesis in hairless mouse epidermis. J Invest Dermatol 1968;51:445-53.
12. Kramer DM, Pathak MA, Kernhauser A, et al. Effect of ultraviolet irradiation on biosynthesis of DNA in guinea pig skin. J Invest Dermatol 1974;62:388-93.
13. Epstein WL, Fukuyama K, Epstein JH. Early effects of ultraviolet light on DNA synthesis in human skin in vivo. Arch Dermatol 1969;100:84-9.
14. Rosario R, Mark GJ, Parrish JA, et al. Histological changes produced in skin by equally erythemogenic doses of UV-A, UV-B, UV-C and UV-A with psoralens. Br J Dermatol 1979;101:299-308.
15. Cruz Jr PD. Photoimmunology. In: Deleo VA, editor. Topics in clinical dermatology, photosensitivity. New York, Tokyo: Ingaku-Shoin, 1992:25-32.
16. McKenzie RC, Sauder DM. Keratinocyte cytokine and growth factors: Functions in skin immunity and homeostasis. Dermatol Clin 1990;8:649-61.
17. Young E, van der Leun JC. Treatment of psoriasis with longwave ultraviolet light. Dermatologica 1975;150:352-4.
18. Parrish JA. The treatment of psoriasis with longwave ultraviolet light (UV-A). Arch Dermatol 1977;113:1525-8.
19. Van Weelden H, Young E, van der Leun JC. Therapy of psoriasis: Comparison of photochemotherapy and several variants of phototherapy. Br J Dermatol 1980;103:1-9.
20. Bernhard JD, Enoch T, Parrish JA. Ultraviolet action
21. spectrum for the Koebner reaction in psoriasis. J Invest Dermatol 1982;78:346.
22. Fitzpatrick TB. Soleil et peau. J Med Esthet 1975;2:33-8.
23. Chung JH, Koh WS, Youn JI. Relevance of skin phototyping to a Korean population. Clin Ex Dermatol 1994;19:476-8.
24. Snellman E, Jansen CT, Leszczynski Z, et al. Ultraviolet erythema sensitivity in anamnestic (I-IV) and phototested (1-4) Caucasian skin phototypes: The need for a new classification system. Photochem Photobiol 1995;62:769-72.
25. Pathak MA, Fitzpatrick TB. Preventive treatment of sunburn dermatoheliosis, and skin cancer with sun-protective agents. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill, 1993:1689-717.
26. Petrozzi JW, Reyes ODL. Comparison of once-daily and twice-daily ultraviolet radiation treatments in psoriasis. Arch Dermatol 1981;117:695-7.
27. Boer J, Schothorst AA, Suurmond D. UV-B phototherapy of psoriasis. Dermatologica 1980;161:250-8.
28. Adrian RM, Parrish JA, Momtaz K, et al. Outpatient phototherapy for psoriasis. Arch Dermatol 1981;117:623-6.
29. Stern RS, Armstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: A randomized study. J Acad Dermatol 1986;15:546-52.
30. Taylor CR, Stern RS. Magnitude and duration of UV-B-induced tolerance. Arch Dermatol 1991;127:673-7.
31. Paul BS, Larko O, Swanbeck G, et al. Therapeutic photomedicine: phototherapy. In: Fitzpatrick TB, Eisen AZ, et al. editors. Dermatology in general medicine. New York: McGraw-Hill, 1993:1717-27.
32. Goeckerman WH. Treatment of psoriasis. Northwest Med 1925;24:229-31.
33. Grupper C. The chemistry, pharmacology and use of tar in the treatment of psoriasis. In: Farber EM, Cox AJ, editors. Psoriasis, Proceedings of the International Symposium on Psoriasis. Stanford, CA: Stanford University Press, 1971:347-56.
34. Epstein E. Photosensitization in the treatment of psoriasis. J Invest Dermatol 1947;8:203-7.
35. Young E. Ultraviolet therapy of psoriasis: A critical study. Br J Dermatol 1972;87:379-82.
36. Marisco AR, Zaglestein WH, Weinstein G. Ultraviolet light and tar in the Goeckerman treatment of psoriasis. Arch Dermatol 1976;112:1249-50.
37. Frost P, Horwitz SN, Caputo RV, et al. Tar gel-phototherapy for psoriasis: Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation. Arch Dermatol 1979;115:840-6.
38. Petrozzi JW, Barton JG, Kaidberg KK, et al. Updating the Goeckerman regimen for psoriasis. Br J Dermatol 1978;98:437-44.
39. Anderson TF, Waldinger TP, Voorhees JJ. UV-B phototherapy. Arch Dermatol 1984;120:1502-7.
40. Anderson RR, Parrish JA. Optical properties of human skin. In: Regan JD, Parrish JA, editors. The science of photomedicine. New York: Plenum Press, 1980:147-94.
41. Farr PM, Diffey BL, Steele MC. A preliminary study on the in vivo transmission of light through psoriatic plaques. Photodermatology 1984;1:87-90.
42. Leroy D, Dompmartin A, Daschamps P. Increased penetration of epidermis by high intensity ultraviolet rays following the application of vaseline oil. Photodermatology 1986;3:51-2.
43. Surton JD. The sunscreening effect of topical sunflower oil J Am Acad Dermatol 1983;8:909-10.
44. Schleider NR, Moskowitz RS, Cont DH et al. Effects of emollients on ultraviolet-radiation-induced erythema of the skin. Arch Dermatol 1979;115:1188-91.
45. Berne B, Blom I, Spangberg S. Enhanced response of psoriasis to UVB therapy after pre-treatment with a lubricating base. A single blind controlled study. Acta Derm Venereol (Stockh) 1990;70:474-7.
46. Hudson-Peacock MS, Diffey BL, Fair PM. Photoproteetive action of emollients in ultraviolet therapy of psoriasis. Br J Dermatol 1994;130:361-5.
47. Kristensen B, Kristensen O. Topical salicylic acid interferes with UVB therapy for psoriasis. Acta Derm Venereol (Stockh) 1991;71:37-40.
48. Ingram IT. The approach of psoriasis. Br Med ) 1953;2:591-4.
49. Farber EM, Harris DR. Hospital treatment of psoriasis: a modified anthralin program. Arch Dermatol 1970;101:381-9.
50. Farber EM, Abel EA, Charuworn A. Recent advances in the treatment of psoriasis. J Am Acad Dermatol 1983;8:311-9.
51. Statham BN, Ryatt KS, Rowell NR. Short-contact dithranol therapy - a comparison with the Ingram regimen. Br J Dermatol 1984;110:703-8.
52. Lebwohl M, Berman B, France DS. Addition of short-contact anthralin therapy to an ultra-violet B phototherapy regimen: assessment of efficacy. J Am Acad Dermatol 1985;13:780-4.
53. Larko O, Swanbeck G. Psoriasis treatment and a daycare centre: Clinical aspects and an attempt at a cost-benefit analysis. Acta Derm Venereol (Stockh) 1982;62:413-8.
54. Brandt H. Ditrastick combined with UVB. An alternative regimen for plaque psoriasis. Acta Derm Venereol Suppl (Stockh). 1989;146:102-3.
55. Cornell RC, Stoughton RB. The use of tropical steroids in psoriasis, Dermatol Clin 1984;2:397-409.
56. Allison F, Smith MR, Wood WB. Studies on the pathogenesis of acute inflammation II. The action of cortisone on the inflammatory response to thermal injury. J Exp Med 1955;102:669-75.
57. Fisher LB, Maibach HI. The effect of corticosteroid on human epidermal mitotic activity. Arch Dermatol 1971;103:39-44.
58. Le Vine MJ, Parrish JA. The effect of topical fluocinonide ointment on phototherapy of psoriasis. J Invest Dermatol 1982;78:157-9.
59. Petrozzi JW. Topical steroids and UV radiation in psoriais. Arch Dermatol 1983;119:207-10.
60. Dover J, McEvoy MT, Rosen CF, et al. Are topical corticosteroids useful in phototherapy for psoriasis? J Am Acad Dermatol 1989;20:748-54.
61. Larko O, Swanbeck G, Svartholm H. The effect on psoriasis of clobetasol propionate used alone or in combination with UVB. Acta Derm Venereol (Stockh) 1984;64:151-4.
62. Horwitz SN, Johnson RA, Sefton J, et al. Addition of a topically applied corticosteroid to a modified Goeckerman regimen for treatment of psoriais: Effect on duration of remission. J Am Acad Dermatol 1985;13:784-91.
63. Kragballe K. Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris. Dermatologica 1990;181:211-4.
64. Kerscher M, Volkenandt M, Plewig G, et al. Combination phototherapy of psoriasis with calcipotriol and narrow band UVB (letter). Lancet 1993;342(8876):923.
65. Kokelj F, Lavaroni G, Guadagnini A. UVB versus UVB plus calcipotriol (MC903) therapy for psoriasis vulgaris. Acta Derm Venereol (Stockh) 1995;75:386-7.
66. Boer J, Schothorst AA, Boom B, et al. Influence of water and salt solutions on UVB irradiation of normal skin and psoriasis. Arch Dermatol Res 1982;273:247-59.
67. Momtaz-TK, Tanghetti E, Parrish JA. Effect of warm water soaks on phototherapy of psoriasis. Clin Res 1982;31:589A.
68. Stern RS, Armstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: A randomized study. J Am Acad Dermatol 1986;15:546-52.
69. Diette KM, Momtaz K, Stern RS, et al. Role of ultraviolet A in phototherapy for psoriasis. J Am Acad Dermatol 1984;11:441-7.
70. Momtaz-TK, Parrish JA. Combination of psoralens and ultraviolet A and ultraviolet B in the treatment of psoriasis vulgaris: a bilateral comparison study. J Am Acad Dermatol 1984;10:481-6.
71. Diette KM, Momtaz-TK, Stern RS, et al. Psoralens and UVA and UVB twice weekly for the treatment of psoriasis. Arch Dermatol 1984;120:1169-73.
72. Morison WL. Combination of methoxsalen and ultraviolet B (UVB) versus UVB radiation alone in the treatment of psoriasis: a bilateral comparison study. Photodermatol Photoimmunol Photomed 1995;11:6-8.
73. Paul BS, Momtaz-TK, Stern RS, et al. Combined methotrexate ultraviolet B therapy in the treatment of psoriasis: J Am Acad Dermatol 1982;7:758-62.
74. Orfanos CE, Steigleder GK, Pullman H, et al. Oral retinoid and UVB radiation: a new alternative treatment for psoriasis on an outpatient basis. Acta Derm Venereol (Stockh) 1979;59:241-4.
75. lest J, Boer J. Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone. Br J Dermatol 1989;120:665-70.
76. Ruzicka T, Sommerberg C, Braun-Fako O, et al. Efficiency of acitretin in combination with UVB in the treatment of severe psoriasis. Arch Dermatol 1990;126:482-6.
77. Lowe NJ, Prystowsky JH, Bourget T, et al. Acetretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acetretin alone. J Am Acad Dermatol 1991;24:591-4.
78. Oikarinen A, Peltonen J, Kallioinen M. Ultraviolet radiation in skin ageing and carcinogenesis: the role of retinoids for treatment and prevention. Ann Med 1991;23:497-505.
79. Roenigk RK, Gibstine C, Roenigk HH. Oral isotretinoin followed by psoralens and ultraviolet A or ultraviolet B for psoriasis. J Am Acad Dermatol 1985;13:153-5.
80. Black AK, Fincham N, Greaves MW, et al. Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 alpha in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 1980;10:453-7.
81. Schwarz T, Luger TA. Effect of UV irradiation on epidermal cell cytokine production. J Photochem Photobiol 1989;B4:1-13.
82. Fitzpatrick TB. Sunlight and skin cancer. N Eng J Med 1985;313:818-9.
83. Pittelkow MR, Perry HO, Muller SA, et al. Skin cancer in patients with psoriasis treated with coal tar. Arch Dermatol 1981;117:465-8.
84. Larko O, Swanbeck G. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol (Stockh) 1982;62:507-12.
85. Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet 1980;1:732-5.
86. Stern RS. Members of the photochemotherapy follow up study. Genital tumours among men with psoriasis exposed to psoralens and ultraviolet radiation (PUVA) and ultraviolet B radiation. N Eng J Med 1990;322:1093-97.
87. Studniberg HM, Weller P. PUVA, UVB, psoriasis and non melanoma skin cancer. J Am Acad Dermatol 1993;29:1013-22.
88. Taylor CR, Stern RS, Leyden JT, et al. Photoaging, photodamage and photoprotection. J Am Acad Dermatol 1990;22:1-15.
89. Diffey BL, Farr PM. An appraisal of ultraviolet lamps used for the phototherapy of psoriasis. Br J Dermatol 1987;117:49-56.
90. Van Weelden H, Baart de la Faille H, Young E, et al. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988;119:11-19.
91. Karvonen J, Kokkohen EL, Routsalainen E. 311 run UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol (Stockh) 1989;69:82-5.
92. Green C, Ferguson J, Lakshmipathi T, et al. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988;119:691-6.
93. Larko O. Treatment of psoriasis with a new UVB-lamp. Acta Derm Venereol (Stockh) 1989;69:357-9.
94. Picot E, Meunier L, Picot-Debeze MC, et al. Treatment of psoriasis with a 311 nm UVB lamp. Br J Dermatol 1992;127:509-12.
95. Storbeck K, Holzle E, Schurer N, et al. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993;28:227-331.
96. Green C, Lakshmipathi T, Johnson BE, et al. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs etretinate (re-TL-01) vs etretinate-PUVA (re-PUVA) in the treatment of psoriais patients. Br J Dermatol 1992;127:5-9.
97. Sakuntabhai A, Diffey BL, Farr PM. Response of psoriasis to psoralens-UVB photochemotherapy. Br J Dermatol 1993;128:296-360.
98. Farr PM, Differy BL, Higgins EM, et al. The action spectrum between 320 and 400 nm for clearance of psoriasis by psoralen photochemotherapy. Br J Dermatol 1991;124:443-8.
99. Ortel B, Perl S, Kinaciyan T, et al. Comparison of narrowband (311 nm) UVB and broad-band UVA after oral or bath-wash 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 1993;29:736-40.
100. George SA, Ferguson J. Lesional blistering following narrow-band (TL-01) UVB phototherapy for psoriasis: a report of four cases. Br J Dermatol 1992;127:445-6.
101. Ortel B, Honigsmann H. New techniques in phototherapy. Curr Opin Dermatol 1993:191-3.
102. Hansen AB, Bech-Thomsen N, Wulf HC. Erythema after irradiation with ultraviolet B from Philips TL12 and TL01 tubes. Photodermatol Photoimmunol Photomed 1994;10:22-5.
103. Sterenborg HJCM, Van Weelden H, van der Leun JC. The dose-response relationship for tumorigenesis by UV radiation in the region 311-312 nm. J Photochem Photobiol B:Biol 1988;2:179-94.
104. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's Syndrome. Arch Dermatol 1987;123:1622-32.
105. Duvic M. Human Immunodeficiency virus and the skin: selected controversies. J Invest Dermatol 1995;105(Supp): 117S-21S.
106. Morison WL, Parrish JA, Bloch KJ, et al. In vivo effect of UV-B on lymphocytic function. Br J Dermatol 1979;101:513-9.
107. Morrey JD, Bourn SM, Bundi TD, et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 1991, 65:5045-51.
108. Valerie K, Delers A, Bruck C, et al. Activation of human immunodeficiency virus type I by DNA damage in human cells. Nature 1988;333:78-81.
109. Cavard C, Zider A, Vernet M, et al. In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest 1990;86:1369-74.
110. Meola J, Soter NA, Ostreicher R, et al. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 1993;29:216-20.
111. Fotiades J, Lim HW, Jiang SB, et al. Efficacy of ultraviolet B phototherapy for psoriasis in patients infected with human immunodeficiency virus. Photodermatol Photoimmunol Photomed 1995;11:107-11.